Company news
Liminal BioSciences Inc news in 2019
Liminal BioSciences Inc's news releases, calls and decks from 2019, newest first.
Liminal BioSciences Comments on Unusual Market Activity
December 23, 2019
AMF Concludes its Review of the Refinancing Transactions Completed by Liminal BioSciences in April 2019
November 28, 2019
Liminal BioSciences to Present at Piper Jaffray Healthcare Conference
November 27, 2019
Liminal BioSciences announces closing of divestiture of bioseparations division to KKR
November 25, 2019
Liminal Presents New Preclinical Data on PBI-4050 and its Effect on Angio-Proliferative Pulmonary Arterial Hypertension
November 18, 2019
Liminal BioSciences to Present at the Jefferies 2019 London Healthcare Conference
November 18, 2019
Liminal Biosciences announces effectiveness of Registration Statement on Form F-10 and filing of Prospectus Supplement
November 18, 2019
Liminal BioSciences to Present at Stifel Healthcare Conference
November 15, 2019
Liminal BioSciences to Commence Trading Common Shares on NASDAQ
November 15, 2019
/C O R R E C T I O N from Source -- Liminal BioSciences Inc./
November 14, 2019
Liminal Biosciences Announces Key Appointment to its Leadership Team
November 13, 2019
Liminal BioSciences Presents New Preclinical Data on PBI-4050 and NASH Candidate PBI-4547
November 12, 2019
Liminal BioSciences to Report Q3 2019 Results and Hold Conference Call
November 11, 2019
Liminal BioSciences Reports its 2019 Third Quarter Financial Results and Business Highlights
November 11, 2019
Liminal Biosciences Presents New Preclinical Data at ASN Kidney Week 2019
November 11, 2019
Liminal BioSciences to Divest Bioseparations Division to KKR
November 4, 2019
Liminal BioSciences announces upcoming presentations new data on pulmonary arterial hypertension at the 2019 AHA meeting
October 29, 2019
Liminal BioSciences announces upcoming presentations at The Liver Meeting 2019
October 25, 2019
Liminal BioSciences Announces Upcoming Presentations at ASN Kidney Week 2019
October 24, 2019
Liminal BioSciences to Present At H.C. Wainwright & Co. 3rd Annual NASH Investor Conference
October 18, 2019
Prometic Shareholders Approve Name Change to Liminal BioSciences Inc.
October 3, 2019
Prometic Life Sciences Announces Intention to Change Name to Liminal BioSciences Inc.
September 3, 2019